RHS Financial’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
RHS Financial's BMY Position: Q2 2026 in Review
RHS Financial reduced its Bristol-Myers Squibb (BMY) stake by 5% in Q2 2026, selling an estimated $35.7K and leaving 11,816 shares worth $681K. The position accounts for 0.27% of the portfolio, ranked #74.
RHS Financial first reported a position in BMY in Q2 2025 and has held it in 5 quarters since. The position peaked at $754K in Q1 2026. 2,523 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- RHS Financial held 11,816 shares of Bristol-Myers Squibb worth $681K as of Q2 2026.
- RHS Financial sold 622 Bristol-Myers Squibb shares in Q2 2026, an estimated $35.7K.
- Bristol-Myers Squibb made up 0.27% of RHS Financial's portfolio in Q2 2026, its #74 holding.
- RHS Financial first reported a position in Bristol-Myers Squibb in Q2 2025 and has held it in 5 quarters since.
- RHS Financial's Bristol-Myers Squibb position peaked at $754K in Q1 2026.
- 2,523 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on RHS Financial's 13F filing for Q2 2026, filed 7 Aug 2026.